miR-138 inhibits the occurrence and development of ovarian cancer by downregulating the expression of SOX12 gene [36] and invasion via SOX4 and HIF-1α oncogenic transcriptional factors [37]. The gene discussed is SOX4; the disease is ovarian cancer.